Want to join the conversation?
$LLY 2Q15 PR: Expects 2015 revenue to be $19.7-20.0Bil vs. prior guidance of $19.5-20.0Bil, reflecting solid 1H15 underlying performance, including the launch trajectories of Jardiance, Trulicity & Cyramza. 2015 financial outlook is subject to final acquisition accounting adjustments for acquisitions of Novartis Animal Health and Erbitux rights.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.